CY1109807T1 - Προσδιορισμος της οξειδασης της διαμινης - Google Patents

Προσδιορισμος της οξειδασης της διαμινης

Info

Publication number
CY1109807T1
CY1109807T1 CY20091100699T CY091100699T CY1109807T1 CY 1109807 T1 CY1109807 T1 CY 1109807T1 CY 20091100699 T CY20091100699 T CY 20091100699T CY 091100699 T CY091100699 T CY 091100699T CY 1109807 T1 CY1109807 T1 CY 1109807T1
Authority
CY
Cyprus
Prior art keywords
diamine
sample
derivatized
amount
determination
Prior art date
Application number
CY20091100699T
Other languages
English (en)
Inventor
Isabella Mayer
Albert Missbichler
Original Assignee
Sciotec Diagnostic Technologies Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sciotec Diagnostic Technologies Gmbh filed Critical Sciotec Diagnostic Technologies Gmbh
Publication of CY1109807T1 publication Critical patent/CY1109807T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/17Nitrogen containing
    • Y10T436/173845Amine and quaternary ammonium

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Εδώ γνωστοποιείται μια μέθοδος για τον προσδιορισμό της δραστηριότητας της ισταμίνης (DAO; EC 1.4.3.6) μέσα σε ένα δείγμα. Η αναφερόμενη μέθοδος περιέχει τα ακόλουθα βήματα: παρέχεται ένα υδατικό διάλυμα το οποίο περιέχει μια προκαθορισμένη ποσότητα διαμίνης· το υδατικό διάλυμα αναμιγνύεται και επωάζεται σε μία προκαθορισμένη χρονική περίοδο σε περιπτώσεις, με τις οποίες η διαμίνη μπορεί να αντιδράσει με την DAO που είναι πιθανών παρούσα στο δείγμα· η διαμίνη παραγωγίζεται· η ποσότητα του παράγωγου της διαμίνης προσδιορίζεται· η προκαθορισμένη ποσότητα διαμίνης συγκρίνεται με την ποσότητα του παράγωγου της διαμίνης· και προσδιορίζεται η πιθανών παρούσα δραστικότητα της ισταμίνης.
CY20091100699T 2005-11-18 2009-07-03 Προσδιορισμος της οξειδασης της διαμινης CY1109807T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0188105A AT502850B1 (de) 2005-11-18 2005-11-18 Verfahren zur bestimmung der aktivität von diaminooxidase
EP06804394A EP1948819B1 (de) 2005-11-18 2006-11-17 Bestimmung von diaminooxidase

Publications (1)

Publication Number Publication Date
CY1109807T1 true CY1109807T1 (el) 2014-09-10

Family

ID=37806678

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091100699T CY1109807T1 (el) 2005-11-18 2009-07-03 Προσδιορισμος της οξειδασης της διαμινης

Country Status (9)

Country Link
US (1) US8003343B2 (el)
EP (1) EP1948819B1 (el)
AT (2) AT502850B1 (el)
AU (1) AU2006315062B2 (el)
CA (1) CA2629061C (el)
CY (1) CY1109807T1 (el)
DE (1) DE502006003494D1 (el)
ES (1) ES2323553T3 (el)
WO (1) WO2007056788A1 (el)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2020446A1 (en) * 2007-07-31 2009-02-04 Denis Vincent Compositions and methods for detecting histamine related disorders
US12201676B2 (en) 2011-03-18 2025-01-21 Dr Healthcare España, S.L. Composition comprising diamine oxidase for use in the treatment or prevention of fibromyalgia or chronic fatigue syndrome
ES2388166B1 (es) * 2011-03-18 2013-10-01 Dr Healthcare España, S. L. Alimentos funcionales que contienen diaminooxidasa y sus usos.
ES2388395B1 (es) * 2011-03-18 2013-10-01 Dr Healthcare España, S. L. Uso de la diaminooxidasa para el tratamiento o la prevención de la fibromialgia o la fatiga crónica.
ES2387973B1 (es) * 2011-03-18 2013-10-01 Dr Healthcare España, S. L. Composiciones tópicas que contienen diaminooxidasa para el tratamiento o la prevención de enfermedades asociadas a un nivel de histamina elevada que comportan un aumento del dolor.
ES2426539B1 (es) 2012-04-18 2014-09-09 Dr Healthcare España, S. L. Uso de la diaminooxidasa para el tratamiento o la prevención del trastorno por deficit de atencion con hiperactividad (adhd)
JP6478255B2 (ja) * 2015-03-04 2019-03-06 株式会社島津製作所 蛍光誘導体化試薬及びアミン分析方法
EP3752838B1 (de) 2018-02-16 2022-08-03 Frost Diagnostika GmbH Methode zur bestimmung der totalen histamin-abbaukapazität in biologischen proben
US20230109016A1 (en) 2020-02-10 2023-04-06 Immundiagnostik Ag In-vitro diagnosis of histamine intolerance syndrome
CN111504986A (zh) * 2020-04-03 2020-08-07 上海理工大学 一种快速检测二胺类生物胺的方法
EP4134672A1 (en) 2021-08-09 2023-02-15 Immundiagnostik AG Differential diagnosis of histamine intolerance syndrome
WO2023017050A1 (en) 2021-08-10 2023-02-16 Immundiagnostik Ag Differential diagnosis of histamine intolerance syndrome

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2562671B1 (fr) 1984-04-10 1986-07-25 Immunotech Sa Procede pour le dosage immunologique des monoamines
EP0400086B1 (en) * 1988-02-08 1993-01-27 University College Cardiff Consultants Ltd. Detection of diamines in biological fluids
WO1990010061A1 (en) * 1989-03-02 1990-09-07 Griffith University Diamine oxidase and assay for rupture of amniotic membrane in pregnant mammals
AT411688B (de) * 2002-10-31 2004-04-26 Jarisch Reinhard Dr Verfahren zur bestimmung der aktivität von diaminooxidase
US20050214894A1 (en) * 2004-03-26 2005-09-29 Schofield Christopher J High throughput assay

Also Published As

Publication number Publication date
AT502850B1 (de) 2007-08-15
US20080227116A1 (en) 2008-09-18
US8003343B2 (en) 2011-08-23
CA2629061C (en) 2017-10-10
WO2007056788A1 (de) 2007-05-24
EP1948819A1 (de) 2008-07-30
AU2006315062B2 (en) 2011-11-17
DE502006003494D1 (de) 2009-05-28
AT502850A1 (de) 2007-06-15
ES2323553T3 (es) 2009-07-20
AU2006315062A1 (en) 2007-05-24
EP1948819B1 (de) 2009-04-15
CA2629061A1 (en) 2007-05-24
WO2007056788A8 (de) 2007-08-09
ATE428799T1 (de) 2009-05-15

Similar Documents

Publication Publication Date Title
CY1109807T1 (el) Προσδιορισμος της οξειδασης της διαμινης
WO2008060694A3 (en) System and/or method for determining sufficiency of pseudorange measurements
ATE523874T1 (de) Adaptive stimmenmodus-erweiterung für einen stimmenaktivitäts-detektor
BR0311175A (pt) Processo e sistema de reagente com complexo de enzima-coenzima não regenerável
TW200703931A (en) Apparatus and methods for control of sleep modes in a transceiver
SG170826A1 (en) Oral dosage forms including an antiplatelet agent and an acid inhibitor
DE602006019476D1 (de) Verwendung von filterung und aktiver prüfung zur evaluierung eines datentransferweges
WO2006117689A3 (en) Method for diagnosing multiple sclerosis
BRPI0507376A (pt) espécie oxidável como uma referência interna para biossensores e método de uso
ATE461276T1 (de) Enzymstabilisierung
TW200632312A (en) Method for analyzing haemoglobin by capillary electrophoresis, a kit for capillary electrophoresis, and use of a flow inhibitor in said method
TW200641137A (en) A method for quantifying cholesterol of remnant-like particles lipoprotein, reagent and kit
IL166539A (en) Method for diagnosing multiple sclerosis
MXPA04004880A (es) Composiciones y metodos para el diagnostico temprano y preciso de prenez.
TW200720436A (en) A process for measuring the cholesterol in high density lipoprotein
UA83737C2 (ru) Способ снижения содержания цианида в образце мезотриона
WO2009126889A8 (en) Assays for detecting pregnancy-associated glycoproteins
WO2007113854A8 (en) A biosensor to determine potassium concentration in human blood serum
SG135122A1 (en) Fast microbiological analysis method
DE602005024254D1 (el)
EP1342790A3 (en) Reagent and method for measuring amylase activity
TNSN07428A1 (en) Method
TW200644111A (en) Monitor method for the concentration of etching liquid
DE602006016978D1 (de) Endotoxinanalyse
WO2007032717A8 (en) A method for identifying an agent that modulates arginine transport in a chondrocyte